// App-Quantinova.ai

3568 : Prognostic value of programmed death-ligand 1 (PD-L1) expression in patients with stage III colorectal cancer.

Researchers

Presenter

  • Shigehiro Koganemaru

Principal Investigators

  • Naoko Inoshita

  • Yuji Miura

  • Yudai Fukui

  • Yukinori Ozaki

  • Kenji Tomizawa

  • Yutaka Hanaoka

  • Shigeo Toda

  • Koichi Suyama

  • Yuko Tanabe

  • Jin Moriyama

  • Takeshi Fujii

  • Shuichiro Matoba

  • Hiroya Kuroyanagi

  • Toshimi Takano

Medical Centers

  • Department of Hematology, Toranomon Hospital, Tokyo, Japan

  • Department of Hematology, Toranomon Hospital, Tokyo, Japan

  • Department of Gastroenterological Surgery, Toranomon Hospital, Tokyo, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Colorectal Cancer

Biomarkers

  • Programmed death-ligand 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved